Pfizer to Spend $470 Million to Expand Vaccine Operations
PEARL RIVER—Global pharmaceutical firm Pfizer Inc. reports that it will spend $470 million to expand its vaccine research and development operations here. As Bloomberg first reported, Pfizer confirmed to Real Estate In-Depth that it plans over the next three years to secure necessary approvals and expand and modernize its campus with a new 260,000-square-foot lab building. The project will feature a total of 55,000 square feet of lab space. The new space is expected to be operational in 2026. The plan by the Manhattan-headquartered firm, also calls for the addition of amenities such as a modern café, fitness center, parking garage...